Also, in DIO/MetS/T2DM, we presently do not know if β‐cell aPKC activity is altered downward (as in muscle—see below), or upward (as in liver), in which case, it may participate in mediating compensatory increases in insulin secretion. The gene discussed is INS; the disease is metabolic syndrome.